{"DataElement":{"publicId":"7295351","version":"1","preferredName":"Tumor Mass Site Glioblastoma Glioblastoma Anatomic Site","preferredDefinition":"The named locations of a malignant astrocytic tumor (WHO grade IV) which is preferentially located in the cerebral hemispheres of the brain.","longName":"6796604v1.0:7295350v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796604","version":"1","preferredName":"Tumor Mass Site","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._The anatomic site of the tumor.","longName":"4976411v1.0:6796602v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6796602","version":"1","preferredName":"Site of Tumor","preferredDefinition":"The anatomic site of the tumor.","longName":"C157120","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Site of Tumor","conceptCode":"C157120","definition":"The anatomic site of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C3BB458-85EF-345F-E053-F662850AA4D3","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"ONEDATA","dateModified":"2019-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C3BB458-8600-345F-E053-F662850AA4D3","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-01-02","changeDescription":"1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF.   7/26/19 jk revised OC concept per CPTAC input.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7295350","version":"1","preferredName":"Glioblastoma Glioblastoma Anatomic Site","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV).  It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma, IDH-mutant), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma, IDH- wildtype). (Adapted from WHO)_Named locations of or within the body.","longName":"7295350v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Frontal Lobe","valueDescription":"Frontal Lobe","ValueMeaning":{"publicId":"2688392","version":"1","preferredName":"Frontal Lobe","longName":"2688392","preferredDefinition":"The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Frontal Lobe","conceptCode":"C12352","definition":"The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C184D1B-1F42-4051-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-10-09","modifiedBy":"COOPERM","dateModified":"2021-05-13","changeDescription":"5.13.21 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A5A380C0-19BF-219C-E053-F662850A5C6C","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"Occipital Lobe","valueDescription":"Occipital Lobe","ValueMeaning":{"publicId":"2688395","version":"1","preferredName":"Occipital Lobe","longName":"2688395","preferredDefinition":"One of the four regions of cortex in each cerebral hemisphere. It is located posterior to the temporal lobe and inferior to the parietal lobe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occipital Lobe","conceptCode":"C12355","definition":"One of the four regions of cortex in each cerebral hemisphere. It is located posterior to the temporal lobe and inferior to the parietal lobe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C184D1B-1FAE-4051-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-10-09","modifiedBy":"COOPERM","dateModified":"2021-05-26","changeDescription":"5.26.21 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A5A380C0-19C9-219C-E053-F662850A5C6C","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"Other","valueDescription":"Specify Other","ValueMeaning":{"publicId":"6782229","version":"1","preferredName":"Specify Other","longName":"6782229","preferredDefinition":"A directive to indicate a response not listed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify Other","conceptCode":"C157106","definition":"A directive to indicate a response not listed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-90A3-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"TSESU","dateModified":"2022-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A5A380C0-19D3-219C-E053-F662850A5C6C","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"Parietal Lobe","valueDescription":"Parietal Lobe","ValueMeaning":{"publicId":"2688394","version":"1","preferredName":"Parietal Lobe","longName":"2688394","preferredDefinition":"One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main functions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parietal Lobe","conceptCode":"C12354","definition":"One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C184D1B-1F8A-4051-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-10-09","modifiedBy":"COOPERM","dateModified":"2021-05-26","changeDescription":"5.26.21 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A5A380C0-19DD-219C-E053-F662850A5C6C","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"Temporal Lobe","valueDescription":"Temporal Lobe","ValueMeaning":{"publicId":"2688393","version":"1","preferredName":"Temporal Lobe","longName":"2688393","preferredDefinition":"Lower lateral part of the cerebral hemisphere.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Temporal Lobe","conceptCode":"C12353","definition":"One of the cerebral lobes. It is located inferior to the frontal and parietal lobes and anterior to the occipital lobe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C184D1B-1F66-4051-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-10-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A5A380C0-19E7-219C-E053-F662850A5C6C","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7295349","version":"1","preferredName":"Glioblastoma Anatomic Site","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV).  It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma, IDH-mutant), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma, IDH- wildtype). (Adapted from WHO):Named locations of or within the body.","longName":"C3058:C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5A380C0-1997-219C-E053-F662850A5C6C","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"A5A380C0-19A8-219C-E053-F662850A5C6C","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"KNABLEJ","dateModified":"2020-05-14","changeDescription":"5/14/20 jk created for CPTAC GBM baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779547","version":"1","longName":"GBM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Site","type":"Preferred Question Text","description":"Tumor Site","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"A5A37A39-9406-245E-E053-F662850A29FC","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-14","modifiedBy":"KNABLEJ","dateModified":"2020-05-14","changeDescription":"5/14/20 jk created for CPTAC GBM baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}